What did @wolfongear actually say?
The creator laid out a peptide stack they describe as "the ultimate" cycle for getting "jacked, shredded, and recovered." The lineup includes IGF-1, a GLP-1 receptor agonist (called "RETA or GOP three," almost certainly semaglutide or retatrutide), testosterone, BPC-157, TB-500, and AOD-9604. For each compound, they assigned a specific role: IGF-1 for muscle bellies and nutrient partitioning, the GLP-1 drug for energy expenditure, testosterone for visceral fat and lipolysis, the healing peptides for tendon and ligament repair, and AOD for lower belly fat mobilization. The video is framed casually, without dosing caveats or safety warnings. The audience is clearly assumed to be people who already know what these compounds are, or are about to go find out.
Does the science back this up?
Partially, and the devil is entirely in the details. Some of the underlying biology is real. Most of the marketing language around it is not. IGF-1 does play a role in muscle protein synthesis and nutrient partitioning, but exogenous IGF-1 administration in humans carries serious risks including hypoglycemia and potential tumor promotion (Beletsky and Bhatt, 2021, StatPearls). GLP-1 receptor agonists genuinely reduce energy intake and body weight, with robust clinical trial data behind semaglutide specifically (Wilding et al., 2021, NEJM). Testosterone does affect body composition, including visceral adiposity (Traish et al., 2014, Journal of Cardiovascular Pharmacology and Therapeutics). BPC-157 shows promising tendon and ligament healing data, but almost entirely in rodent models (Chang et al., 2011, Journal of Applied Physiology). AOD-9604 failed its human clinical trials for obesity and was never approved (Heffernan et al., 2001, Journal of Clinical Endocrinology and Metabolism). So the science is real in patches, misrepresented in others, and missing entirely for AOD.
What did they get wrong, and what did they get right?
Let's be fair first. The general functions assigned to GLP-1 agonists and testosterone are not fabricated. Semaglutide does increase energy expenditure and suppress appetite. Testosterone does influence fat distribution. Crediting BPC-157 and TB-500 for tendon repair is consistent with preclinical literature, even if human data is thin.
Now the problems. The creator says IGF-1 sends nutrients "towards your muscles rather than fat storages," implying clean, safe partitioning. That is an oversimplification that ignores IGF-1's documented risks including fluid retention, jaw growth, and insulin resistance at supraphysiological doses. Calling testosterone's mechanism "increase type of genesis" appears to be a garbled reference to adipogenesis, which testosterone actually suppresses in certain fat depots, not increases. The claim that AOD-9604 "forces your body to use your fat cells as energy" is not supported by human evidence. AOD-9604's developer, Metabolic Pharmaceuticals, ran Phase 3 trials that showed no significant weight loss versus placebo (Heffernan et al., 2001). The compound has no approved human use anywhere.
- IGF-1 partitioning claim: oversimplified and omits serious risks
- Testosterone and adipogenesis: mechanistically muddled
- AOD-9604 as a fat mobilizer: not supported by human trial data
- BPC-157 and TB-500 for healing: plausible but preclinical only
What should you actually know?
Several of these compounds, specifically IGF-1 and testosterone, are controlled or regulated substances in most jurisdictions. A GLP-1 receptor agonist like semaglutide is an FDA-approved prescription drug, not a peptide you add to a "stack" casually. Combining them without medical supervision is not a biohacking upgrade, it is a genuine health risk. The World Anti-Doping Agency bans IGF-1 and peptide hormones outright. More practically, stacking anabolic compounds with lipolytic agents and healing peptides creates interaction effects that have not been studied together in any clinical setting. There is no human trial that has examined this combination. The creator presents this as a proven protocol. It is not. It is a theoretical stack assembled from fragmented mechanistic reasoning, animal studies, and gym lore. If any part of this appeals to you, that conversation belongs with a licensed clinician who can order labs and monitor you, not a 60-second TikTok.
Should you be skeptical of the framing?
Yes. The phrase "ultimate stack" is a red flag in any health context. Stacking compounds multiplies both potential benefits and potential harms, and the creator addresses neither harm nor monitoring at any point. Describing this as a cycle for getting "jacked, shredded, and recovered" treats serious pharmacological interventions as if they were supplement pairings. The absence of any mention of blood work, medical oversight, legal status, or side effects is not an oversight, it is a pattern common to performance-enhancement content that keeps deniability intact while walking audiences toward self-prescribing. Be skeptical of any content that packages a multi-drug protocol in under two minutes without a single caveat.